Home / HRTX : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HRTX make money? Does HRTX have pricing power? What's the Earnings Whisper? Will HRTX profit more as the business scales? What is HRTX's management track record? Is HRTX's current price justified?

Heron Therapeutics, Inc.

$0.32 -$0.94 (-74.98%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$0.32

Day Range

$0.31$0.32

Year Range

$0.3$1.58

Market Cap

59.68M

AVG Volume

3.13M

Trailing/Forward PE

-1.68/-

PEG ratio

0.11

Dividend Yield

Next Earnings Date

2026-11-03

Primary Exchange

NASDAQ

Revenue (USD)

HRTX Revenue (USD) by year
Period	Revenue (USD)
2025	154.9M
2024	144.28M
2023	127.04M
2022	107.67M
2021	86.35M
2020	88.64M
2019	145.97M
2018	77.47M
2017	30.77M
2016	1.94M

Net Income (USD)

HRTX Net Income (USD) by year
Period	Net Income (USD)
2025	-20.2M
2024	-13.58M
2023	-110.56M
2022	-182.02M
2021	-220.68M
2020	-227.28M
2019	-204.75M
2018	-178.84M
2017	-197.48M
2016	-173.14M

Operating Income (USD)

HRTX Operating Income (USD) by year
Period	Operating Income (USD)
2025	-2.54M
2024	-11.53M
2023	-110.61M
2022	-174.66M
2021	-217.83M
2020	-228.16M
2019	-210.69M
2018	-183.94M
2017	-194.56M
2016	-170.91M

EBITDA (USD)

HRTX EBITDA (USD) by year
Period	EBITDA (USD)
2025	-12.86M
2024	-5.13M
2023	-102.67M
2022	-184.51M
2021	-216.5M
2020	-222.53M
2019	-201.23M
2018	-174.66M
2017	-193.03M
2016	-169.38M

Cash Flows (USD)

HRTX Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-27.91M
2024	-24.23M
2023	-60.33M
2022	-148.74M
2021	-206.38M
2020	-191.63M
2019	-131.73M
2018	-200.98M
2017	-172.85M
2016	-137.23M

EPS (USD)

HRTX EPS (USD) by year
Period	EPS (USD)
2025	-0.12
2024	-0.09
2023	-0.86
2022	-1.79
2021	-2.25
2020	-2.5
2019	-2.5
2018	-2.47
2017	-3.54
2016	-4.55

Expenses (USD)

HRTX Expenses (USD) by year
Period	Expenses (USD)
2025	116.41M
2024	118.87M
2023	174.1M
2022	229.28M
2021	261.18M
2020	287.43M
2019	302.2M
2018	243.07M
2017	223.29M
2016	175.29M

Cash & Debt (USD)

HRTX Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	46.63M
2024	59.28M
2023	80.41M
2022	84.85M
2021	157.58M
2020	208.49M
2019	390.97M
2018	332.37M
2017	172.38M
2016	51.14M

Debt ratios

HRTX Debt ratios by year
Period	Debt ratios
2025	-0.31
2024	-0.23
2023	-0.14
2022	-0.09
2021	-0
2020	0.23
2019	0.5
2018	0.52

Margins

HRTX Margins by year
Period	Margins
2025	73.31%
2024	73.21%
2023	48.75%
2022	49.04%
2021	46.7%
2020	59.17%
2019	57.79%
2018	64.49%
2017	85.09%
2016	-2187.53%

Return on Capital

HRTX Return on Capital by year
Period	Return on Capital
2025	-140.9%
2024	40.36%
2023	325.43%
2022	-1341.17%
2021	-284.5%
2020	-96.1%
2019	-50.7%
2018	-48.31%
2017	-150.59%
2016	814.75%

Shares Outstanding

HRTX Shares Outstanding by year
Period	Shares Outstanding
2025	166.71M
2024	153.15M
2023	150.28M
2022	119.16M
2021	101.98M
2020	91.08M
2019	89.11M
2018	78.09M
2017	64.72M
2016	39.28M

Book Value Per Share (USD)

HRTX Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.09
2024	-0.22
2023	-0.23
2022	0.11
2021	0.76
2020	2.6
2019	4.53
2018	4.74
2017	2.03
2016	-0.54

Total Assets (USD)

HRTX Total Assets (USD) by year
Period	Total Assets (USD)
2025	255.88M
2024	233.15M
2023	222.51M
2022	250.95M
2021	305.71M
2020	353.56M
2019	512.78M
2018	462.18M
2017	234.31M
2016	67.48M

Employee Count

HRTX Employee Count by year
Period	Employee Count
2025	128
2024	122
2023	126
2022	203
2021	302
2020	223
2019	231
2018	198
2017	145
2016	139

Free Cash Flow Yield

HRTX Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-20.22%
Sep 26	-20.21%
Sep 26	-18.54%
Aug 26	-19.52%
Aug 26	-20.04%
Aug 26	-18.94%
Aug 26	-22.41%
Jul 26	-22.17%
Jul 26	-24.13%
Jul 26	-23.37%
Jul 26	-26.54%
Jul 26	-25.09%
Jun 26	-25.58%
Jun 26	-26.35%
Jun 26	-27.49%
Jun 26	-25.74%
May 26	-12.64%
May 26	-12.81%
May 26	-12.94%
May 26	-13.84%
May 26	-13.18%
Apr 26	-14.07%
Apr 26	-16.74%
Apr 26	-19.63%
Apr 26	-20.95%
Mar 26	-21.36%
Mar 26	-21.5%
Mar 26	-18.99%
Mar 26	-17.32%
Feb 26	-14.07%
Feb 26	-15.49%
Feb 26	-15.9%
Feb 26	-14.51%
Jan 26	-13.85%
Jan 26	-12.87%
Jan 26	-12.27%
Jan 26	-13.15%
Jan 26	-14.51%
Dec 25	-14.28%
Dec 25	-14.06%
Dec 25	-13.34%
Dec 25	-13.96%
Nov 25	-15.76%
Nov 25	-17.25%
Nov 25	-16.62%
Nov 25	-16.62%
Oct 25	-16.53%
Oct 25	-15.98%
Oct 25	-14.86%
Oct 25	-14.98%
Oct 25	-14.53%
Sep 25	-15.85%
Sep 25	-15.59%
Sep 25	-15.22%
Sep 25	-14.64%
Aug 25	-14.2%
Aug 25	-13.7%
Aug 25	-14.42%
Aug 25	-14.53%
Aug 25	-9.14%
Jul 25	-8.08%
Jul 25	-8%
Jul 25	-7.08%
Jul 25	-7.02%
Jun 25	-7.21%
Jun 25	-7.72%
Jun 25	-8%
Jun 25	-7.35%
May 25	-8.21%
May 25	-8.35%
May 25	-7.84%
May 25	-7.32%
May 25	-6.85%
Apr 25	-6.88%
Apr 25	-8.6%
Apr 25	-8.28%
Apr 25	-7.54%
Mar 25	-7%
Mar 25	-6.65%
Mar 25	-6.82%
Mar 25	-6.62%
Feb 25	-6.41%
Feb 25	-3.64%
Feb 25	-3.53%
Feb 25	-3.61%
Jan 25	-3.7%
Jan 25	-3.44%
Jan 25	-3.86%
Jan 25	-4.06%
Jan 25	-3.79%
Dec 24	-4.06%
Dec 24	-3.98%
Dec 24	-3.93%
Dec 24	-3.88%
Nov 24	-5.29%
Nov 24	-5.88%
Nov 24	-5.29%
Nov 24	-8.45%
Nov 24	-8.31%
Oct 24	-7.99%

Price to Sales

HRTX Price to Sales by year
Period	Price to Sales
Sep 26	0.4
Sep 26	0.4
Sep 26	0.43
Aug 26	0.41
Aug 26	0.4
Aug 26	0.42
Aug 26	0.62
Jul 26	0.62
Jul 26	0.57
Jul 26	0.59
Jul 26	0.52
Jul 26	0.55
Jun 26	0.54
Jun 26	0.53
Jun 26	0.5
Jun 26	0.54
May 26	1.09
May 26	1.08
May 26	1.07
May 26	1.3
May 26	1.37
Apr 26	1.28
Apr 26	1.08
Apr 26	0.92
Apr 26	0.86
Mar 26	0.84
Mar 26	0.84
Mar 26	0.95
Mar 26	1.04
Feb 26	1.28
Feb 26	1.3
Feb 26	1.26
Feb 26	1.38
Jan 26	1.45
Jan 26	1.56
Jan 26	1.64
Jan 26	1.53
Jan 26	1.38
Dec 25	1.41
Dec 25	1.43
Dec 25	1.5
Dec 25	1.44
Nov 25	1.27
Nov 25	1.16
Nov 25	1.21
Nov 25	1.21
Oct 25	1.19
Oct 25	1.23
Oct 25	1.33
Oct 25	1.32
Oct 25	1.36
Sep 25	1.24
Sep 25	1.27
Sep 25	1.3
Sep 25	1.35
Aug 25	1.39
Aug 25	1.44
Aug 25	1.37
Aug 25	1.36
Aug 25	1.75
Jul 25	1.97
Jul 25	1.99
Jul 25	2.25
Jul 25	2.27
Jun 25	2.21
Jun 25	2.07
Jun 25	1.99
Jun 25	2.17
May 25	1.94
May 25	1.91
May 25	2.04
May 25	2.18
May 25	2.45
Apr 25	2.44
Apr 25	1.95
Apr 25	2.03
Apr 25	2.23
Mar 25	2.4
Mar 25	2.53
Mar 25	2.46
Mar 25	2.54
Feb 25	2.62
Feb 25	1.92
Feb 25	1.98
Feb 25	1.93
Jan 25	1.89
Jan 25	2.03
Jan 25	1.81
Jan 25	1.72
Jan 25	1.84
Dec 24	1.72
Dec 24	1.75
Dec 24	1.78
Dec 24	1.8
Nov 24	1.32
Nov 24	1.19
Nov 24	1.32
Nov 24	1.95
Nov 24	1.99
Oct 24	2.07

EV/EBITDA

HRTX EV/EBITDA by year
Period	EV/EBITDA
Oct 25	45.73
Oct 25	46.63
Oct 25	48.64
Oct 25	48.42
Oct 25	49.31
Sep 25	46.85
Sep 25	47.3
Sep 25	47.97
Sep 25	49.09
Aug 25	49.98
Aug 25	51.1
Aug 25	49.54
Aug 25	49.31
Aug 25	840.9
Jul 25	914.47
Jul 25	921.16
Jul 25	1004.76
Jul 25	1011.45
Jun 25	991.38
Jun 25	944.57
Jun 25	921.16
Jun 25	978.01
May 25	904.44
May 25	894.41
May 25	934.54
May 25	981.35

Price to Book

HRTX Price to Book by year
Period	Price to Book
Sep 26	8.69
Sep 26	8.69
Sep 26	9.48
Aug 26	9
Aug 26	8.77
Aug 26	9.28
Aug 26	10.19
Jul 26	10.3
Jul 26	9.46
Jul 26	9.77
Jul 26	8.6
Jul 26	9.1
Jun 26	8.93
Jun 26	8.67
Jun 26	8.3
Jun 26	8.87
May 26	18.06
May 26	17.83
May 26	17.64
May 26	14.07
May 26	14.77
Apr 26	13.84
Apr 26	11.63
Apr 26	9.92
Apr 26	9.3
Mar 26	9.12
Mar 26	9.06
Mar 26	10.26
Mar 26	11.24
Feb 26	13.84
Feb 26	13.5
Feb 26	13.16
Feb 26	14.42
Jan 26	15.11
Jan 26	16.25
Jan 26	17.05
Jan 26	15.91
Jan 26	14.42
Dec 25	14.65
Dec 25	14.88
Dec 25	15.68
Dec 25	14.99
Nov 25	13.28
Nov 25	12.13
Nov 25	12.59
Nov 25	12.59
May 23	21.69
Apr 23	20.98
Apr 23	24.23
Apr 23	23.97
Apr 23	20.02
Mar 23	13.26
Mar 23	9.48
Mar 23	11.55
Mar 23	10.75
Mar 23	11.9
Feb 23	11.35
Feb 23	13.44
Feb 23	13.09
Feb 23	14.13
Jan 23	13.89
Jan 23	14.68
Jan 23	15.78
Jan 23	12.54
Dec 22	12.44
Dec 22	12.79
Dec 22	13.64
Dec 22	13.34
Dec 22	13.74
Nov 22	14.28
Nov 22	14.73
Nov 22	17.12
Aug 22	13.73
Jul 22	11.85
Jul 22	11.64
Jul 22	12.53
Jul 22	14.11
Jul 22	11.59
Jun 22	14.49
Jun 22	11.81
Jun 22	9.85
Jun 22	12.79
May 22	14.32
May 22	15.35
May 22	15.3
May 22	5.4
Apr 22	5.94
Apr 22	6.78
Apr 22	7.72
Apr 22	7.66
Apr 22	7.95
Mar 22	7.23
Mar 22	7.23
Mar 22	6.52
Mar 22	6.98
Feb 22	6.47
Feb 22	6.34
Feb 22	7.52
Feb 22	7.32
Jan 22	6.99

No video analysis for this stock yet. Request one from our team.

News: HRTX

seekingalpha.com · 10 Aug 2026

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call Transcript

zacks.com · 10 Aug 2026

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago.

marketbeat.com · 10 Aug 2026

Heron Therapeutics Q2 Earnings Call Highlights

Heron Therapeutics NASDAQ: HRTX reported second-quarter net revenue of $37.7 million, up from $34.7 million in the first quarter and $37.2 million in the comparable prior-year period, while management said sales of its key products came in below its internal expectations.

globenewswire.com · 27 Jul 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

CARY, N.C., July 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, August 10, 2026, at 8:30 a.m. ET to report second quarter financial results and discuss recent business highlights.

zacks.com · 15 Jul 2026

New Strong Sell Stocks for July 15th

BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.